S.J.Res.103 is a Congressional Review Act (CRA) joint resolution that would disapprove and nullify the Department of Veterans Affairs rule titled “Reproductive Health Services” (90 Fed. Reg. 61310, Dec. 31, 2025).
The resolution is short: it declares Congress’s disapproval of that specific rule and states that the rule "shall have no force or effect."
If enacted, the resolution would do more than erase the text of the VA rule. Under the CRA, disapproval blocks the agency from reissuing the same regulation in substantially the same form without explicit congressional authorization.
That combination — immediate nullification plus a bar on reissuance — creates operational, legal, and policy consequences for VA health programs, veterans who use VA care, and interested stakeholders on both sides of reproductive health disputes.
At a Glance
What It Does
The resolution invokes the Congressional Review Act (chapter 8 of title 5, U.S.C.) to disapprove the VA’s “Reproductive Health Services” rule and declares that the rule "shall have no force or effect." It therefore seeks to nullify the rule and to trigger the CRA’s prohibition on reissuing a substantially similar rule without new statutory authorization.
Who It Affects
Directly affected parties include the Department of Veterans Affairs (regulatory staff and health administrators), VA medical centers and clinicians responsible for implementing policy, veterans who would receive care under a changed rule, and advocacy groups and states that litigate or lobby on reproductive-health policy.
Why It Matters
CRA disapprovals are blunt instruments: they erase regulatory text and sharply constrain an agency’s ability to return to the same approach. For VA, that raises questions about access to services, administrative planning, and the agency’s ability to conform care delivery to changing law and medical standards.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
This joint resolution uses the Congressional Review Act to strike down a single VA rule published at 90 Fed. Reg. 61310 on December 31, 2025.
In plain terms: if both chambers pass the resolution and it becomes law, the VA’s published regulatory amendment will have no legal effect. The text of S.J.Res.103 is deliberately minimal because the CRA’s power comes from statute; the joint resolution’s wording simply triggers that statutory remedy.
The resolution’s practical impact goes beyond erasing regulatory text. The CRA contains a separate prohibitory rule: once Congress disapproves a rule under the CRA, the agency generally cannot reissue the same rule in “substantially the same form” unless Congress passes new authorizing law.
That phrase — "substantially the same" — has been the subject of litigation and agency strategy in prior CRA disputes; its ambiguity matters here because it limits how the VA can respond if Congress disapproves.The resolution does not amend the underlying statutes that authorize VA benefits or care; it operates only on the rule text the VA submitted. That means the VA may still be bound by statutory mandates and court decisions that predate or overlap the rule.
If the agency needs to change policy in response to statutory duties or clinical standards, it would have to do so without resurrecting the disapproved regulatory language or seek new congressional authorization.Finally, a statutory disapproval can create operational friction: budget allocations, provider contracts, clinical guidance, and veterans’ expectations that assumed the rule’s existence may require reversal or rework. The resolution itself does not provide transitional mechanisms; implementation questions will fall to VA leadership, potentially prompting litigation or additional rulemaking efforts under a new legal strategy.
The Five Things You Need to Know
The resolution targets the VA rule published at 90 Fed. Reg. 61310 (Dec. 31, 2025) titled “Reproductive Health Services.”, S.J.Res.103 invokes the Congressional Review Act (chapter 8 of title 5, U.S.C.) to enact congressional disapproval of that single rule.
If enacted, the joint resolution declares the VA rule "shall have no force or effect," removing the rule’s legal authority.
CRA disapproval also triggers a statutory prohibition: the VA cannot reissue a rule in "substantially the same form" absent new congressional authorization.
Because this is a joint resolution, it must be passed by both Houses of Congress and presented to the President to become law; only upon enactment do the CRA effects take hold.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Caption and legislative reference
The opening lines identify the instrument as a joint resolution introduced in the Senate and cite the rule by name and Federal Register citation. This formal captioning matters for clerical clarity and ensures the resolution targets a single, identifiable administrative action rather than broader agency policy.
Congress disapproves the specified VA rule
This operative clause states Congress’s formal disapproval of the VA rule. Under the CRA, that pronouncement is the trigger: it converts political opposition into a statutory mechanism for nullifying an executive-branch rule. Practically, this sentence is what courts and agencies will reference to determine that the rule has been disapproved by Congress.
Rule "shall have no force or effect"
The resolution states the nullifying effect in plain language. That phrase is legally consequential: an enacted CRA resolution removes the regulatory force of the published rule as if it had never taken effect. The clause does not itself address transitional or retrospective actions taken pursuant to the rule; those issues typically become subjects of litigation or additional administrative steps.
This bill is one of many.
Codify tracks hundreds of bills on Veterans across all five countries.
Explore Veterans in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Advocacy organizations and legislators who opposed the VA rule — they gain an immediate policy win if the resolution becomes law because it removes the regulatory change they contested.
- State governments and officials that prefer more restrictive reproductive-health policies — they avoid potential federal regulatory changes that could alter state-local enforcement or service landscapes.
- VA administrators and facilities that opposed or were unprepared for the rule’s requirements — nullification spares them the near-term implementation burdens and compliance costs.
- Members of Congress seeking to exercise fast oversight over federal agencies — the resolution provides a clear example of the CRA’s use as a check on executive-branch rulemaking.
Who Bears the Cost
- Veterans who would have benefited from any expanded or clarified services the VA rule provided — they face reduced or uncertain access if the regulation is removed.
- VA clinicians, medical centers, and program managers who began implementation planning — they absorb sunk administrative costs and must pivot policy and training materials.
- The Department of Veterans Affairs itself — the agency will face the operational headache of rescinding guidance, potential litigation, and the constraint on future rulemaking on the same subject.
- Stakeholders seeking uniform federal standards for veterans’ care — disapproval can create a patchwork where services vary by facility, state practice, or litigation outcome, increasing complexity for system-wide administration.
Key Issues
The Core Tension
The central dilemma is congressional speed and control versus administrative expertise and continuity of care: the CRA lets Congress rapidly erase a regulation it dislikes, protecting legislative oversight and certain policy preferences, but doing so also strips an agency of a tool to align veterans’ health services with clinical standards and statutory interpretation — creating uncertainty for providers and beneficiaries that the agency, courts, or Congress must resolve.
The CRA is legally powerful but blunt. Its bar on reissuing a substantially similar rule is purposefully broad and vague; courts have not provided a neat formula for what counts as "substantially the same," so agencies can attempt narrower reworkings or different regulatory approaches that produce fresh litigation over whether the new text crosses the statutory line.
Expect litigation over both the underlying substantive policy and the question whether any subsequent VA action runs afoul of the CRA prohibition.
The resolution acts on regulatory text, not on the statutes that authorize VA benefits. If existing statutes already require or permit certain reproductive-health services, nullifying the rule may leave statutory obligations unresolved rather than eliminating the underlying legal authority for certain services.
Conversely, if the rule represented a new assertion of agency authority not clearly grounded in statute, CRA disapproval can foreclose that administrative pathway — but it does not, by itself, answer the underlying statutory question. That ambiguity raises practical issues for veterans and providers (what care is legally available now), and may force either judicial resolution or fresh congressional action.
Operationally, nullification can create immediate frictions: VA contracts, clinical protocols, and personnel training based on the rule may need reversal, and benefits or coverage decisions made while the rule was in effect could generate litigation over retroactivity and reliance. Finally, using the CRA here is a political choice that substitutes a legislative override for the normal administrative- and notice-and-comment processes; that speed is effective, but it reduces the space for technical fixes and agency-expert tailoring that often follow ordinary rulemaking.
Implementing parties should expect legal challenges and practical disruption even after the resolution becomes law.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.